Boehringer Ingelheim, Tessellate Bio collaborate to develop precision treatments for hard-to-treat cancers Ruchika Sharma25 April 2025 12:30 PM ISTIngelheim: Boehringer Ingelheim and Tessellate Bio, a precision oncology company, have entered into a research collaboration and global license...
Boehringer Ingelheim appoints Shashank Deshpande as Chairman of Board of Managing Directors Ruchika Sharma18 April 2025 4:31 PM ISTIngelheim: Boehringer Ingelheim has announced that Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the...
Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune, inflammatory diseases Ruchika Sharma16 April 2025 10:30 AM ISTBoston: Boehringer Ingelheim and Cue Biopharma, Inc. have announced a strategic research collaboration and license agreement to develop and...
Boehringer Ingelheim gets USFDA priority review for Zongertinib for HER2 (ERBB2)-mutant advanced non-small cell lung cancer treatment Ruchika Sharma20 Feb 2025 11:30 AM ISTIngelheim: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug...
Boehringer Ingelheim launches EURICAN L4 vaccine for leptospirosis in dogs Ruchika Sharma1 Dec 2024 2:00 PM ISTIngelheim: Boehringer Ingelheim has begun its launch of EURICAN L4, delivering a new vaccine to protect dogs against the growing threat of...
Boehringer Ingelheim, Broad Institute of MIT and Harvard to develop treatments for people with mental health conditions Ruchika Sharma8 Nov 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have agreed...
Boehringer Ingelheim gets USFDA Breakthrough Therapy designation for survodutide Ruchika Sharma8 Oct 2024 3:59 PM ISTBoehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI...
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Ruchika Sharma5 Sept 2024 2:30 PM ISTBoehringer Ingelheim acquires Saiba Animal Health, strengthens animal health RnD pipelineIngelheim: Boehringer Ingelheim has said it has acquired...
Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod Ruchika Sharma18 May 2024 2:30 PM ISTMumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a...
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
Boehringer Ingelheim, Sosei Heptares collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia Ruchika Sharma11 March 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and Sosei Group Corporation have announced they have entered a global collaboration and exclusive...
Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals Ruchika Sharma7 March 2024 12:38 PM ISTGerman drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and...
